Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder

Author:

Watmuff Bradley12,Liu Bangyan1,Karmacharya Rakesh123

Affiliation:

1. Center for Experimental Drugs & Diagnostics, Psychiatric & Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Harvard Medical School & Massachusetts General Hospital, Boston, MA 02114, USA

2. Chemical Biology Program, Broad Institute of Harvard & MIT, Cambridge, MA 02142, USA

3. Schizophrenia & Bipolar Disorder Program, McLean Hospital, Belmont, MA 02478, USA

Abstract

The recent advent of induced pluripotent stem cells has enabled the study of patient-specific and disease-related neurons in vitro and has facilitated new directions of inquiry into disease mechanisms. With these approaches, we now have the possibility of correlating ex vivo cellular phenotypes with individual patient response to treatment and/or side effects, which makes targeted treatments for schizophrenia and bipolar disorder a distinct prospect in the coming years. Here, we briefly review the current state of stem cell-based models and explore studies that are providing new insights into the disease biology of schizophrenia and bipolar disorder, which are laying the foundations for the development of novel targeted therapies.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Reference92 articles.

1. Translation of Research Evidence From Animals to Humans

2. Institute of Medicine (US) forum on neuroscience and nervous system disorders. improving the utility and translation of animal models for nervous system disorders: workshop summary (2013). National Academies Press, Washington DC, USA. www.ncbi.nlm.nih.gov/books/NBK117243/.

3. Where is the evidence that animal research benefits humans?

4. Stem cell models of neuropsychiatric disorders

5. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3